MENU
MEOBF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Mesoblast (MEOBF) Ownership - Who owns Mesoblast?
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions... Show more
Profile
Industry
N/A
Address
Level 38, 55 Collins Street
Phone
+61 396396036
Employees
83
Web
https://www.mesoblast.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.1B
P/E Ratio
N/A
Total Cash
161.16M
Projected Growth
N/A
Total Debt
128.16M
Revenue
17.2M
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash/Share
0.13
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
MEOBF
Capitalization
2.11B
P/E Ratio
N/A
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash
161M
Total Cash/Share
0.13
Total Debt
128M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
17.2M
ROE
N/A
Book Value
597M
P/B Ratio
3.43
Cash Flow
N/A
Earnings
-0.08
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.51B
Current Ratio
1.99
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-73.66M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-14.05
Shares Held By Institutions
283M
Shares Outstanding - Current
1.28B
Total Liabilities
187M
Total Volume MTD
N/A
Value
-1
Gain YTD
-27.273
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Level 38, 55 Collins Street
Phone
+61 396396036
Employees
83
Web
https://www.mesoblast.com